Alzheimer’s is a mind-body malaise that experts say can take up to 20 years to run its fearsome course—like having a sliver ...

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

In obesity, Lilly removed a dual amylin calcitonin receptor agonist (DACRA) from its phase 1 pipeline. Lilly got into DACRAs ...

Alzheimer’s disease affects more than 30m people worldwide, mostly the elderly. After the age of 65, the chance of developing ...

Eli Lilly & Company Chairman and CEO Dave Ricks sheds light on growth and success, the increase in weight loss drug ...

Older adults with Alzheimer’s disease and related dementias faced a greater risk for hospitalization after being continuously ...

Taking longer to reach the rapid eye movement (REM) stage of sleep could mean you are more likely to develop dementia.

A new study has found that taking longer to reach the rapid eye movement (REM) stage of sleep is linked to a greater risk of ...

New research from Edith Cowan University (ECU) has shown that diet could influence the risk of both depression and ...

While certain mouth bacteria can boost memory and attention, others were linked to an increased risk of Alzheimer’s disease, ...

Lawson Research Institute of St. Joseph’s Health Care London is receiving $7.2 million in funding for studies in an emerging ...